Wikidata

(Q39213587)

English

Identification of GZD824 as an orally bioavailable inhibitor that targets phosphorylated and nonphosphorylated breakpoint cluster region-Abelson (Bcr-Abl) kinase and overcomes clinically acquired mutation-induced resistance against imatinib.

scientific article published on 28 January 2013

In more languages
default for all languages
No label defined

No description defined

Statements

title
Identification of GZD824 as an orally bioavailable inhibitor that targets phosphorylated and nonphosphorylated breakpoint cluster region-Abelson (Bcr-Abl) kinase and overcomes clinically acquired mutation-induced resistance against imatinib (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23301703
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23301703%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 February 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39213587&oldid=2170806698"